UPDATE : Thursday, December 5, 2019
상단여백
‘Udenafil improved exercise in single ventricle heart disease’
Mezzion Pharma said its investigational drug udenafil improved exercise cap...
by Jeong Sae-im  |  2019-11-18 14:48
라인
“Xalkori-Alecensa sequential therapy advantageous in duration of treatment”
Given the licensing and insurance system in Korea, the Xalkori-Alecensa seq...
by Kim Yun-mi  |  2019-11-15 17:48
라인
Ministry revokes Kolon Life Science’s innovative drug company status
The Ministry of Health and Welfare revoked Kolon Life Science’s innovative ...
by Lee Han-soo  |  2019-11-15 17:26
라인
AbbVie presents new data for ankylosing spondylitis treatment in US
AbbVie has presented positive data from its phase 2 and 3 SELECT-AXIS 1 tri...
by Lee Han-soo  |  2019-11-15 11:40
라인
Merck Korea wins award for helping families with infertility problems
Merck Biopharma Korea said that it received the National Assembly's Hea...
by Lee Han-soo  |  2019-11-14 18:05
라인
Prosecutors raid drugmakers, distributors for suspected bid-rigging
Prosecutors have begun investigating local drug companies and distributors ...
by Jeong Sae-im  |  2019-11-14 15:27
라인
‘Novartis’ Kymriah takes one step closer to cancer cure’
Novartis has recently drawn the attention of local industry watchers concer...
by Lee Han-soo  |  2019-11-14 13:24
라인
iCure to apply for testing incrementally modified cancer drugs in US
iCure BNP said that it plans to apply for a phase 1 trial to change antican...
by Lee Han-soo  |  2019-11-13 17:35
라인
JW Pharmaceutical launches joint-stock company in Vietnam
JW Pharmaceutical said that it has formally launched Euvipharm Joint Stock ...
by Lee Han-soo  |  2019-11-13 16:52
라인
‘Generic drugs must indicate ingredient names on label’
“The results of ranitidine’s recall were sharply different from those of va...
by Kim Yun-mi  |  2019-11-13 15:51
라인
Daewoong releases trial results for autoimmune disease treatment in US
Daewoong Pharmaceutical has presented clinical trial results on DWP212525, ...
by Lee Han-soo  |  2019-11-12 14:09
라인
Hanmi to get ₩11.6 billion in royalty if FDA approves Rolontis
Spectrum, Hanmi’s U.S. partner, said Hanmi can secure 11.6 billion won ($9....
by Lee Han-soo  |  2019-11-11 18:02
라인
Genexine’s new immunotherapy shows stability even in high dose
GX-I7, a new immunotherapy candidate being developed jointly by Genexine an...
by Jeong Sae-im  |  2019-11-11 13:36
라인
Medpacto releases trial results at US conference
Medpacto, a subsidiary of Theregen ETEX, said Monday that it has presented ...
by Lee Han-soo  |  2019-11-11 13:27
라인
Yuhan, Cyclica to co-develop new drugs
Yuhan Corp. said that it would develop a new drug with Cyclica, a Canadian ...
by Lee Han-soo  |  2019-11-07 18:01
라인
Takeda’s labor turmoil goes to extremes amid rumored unit sell-off
Takeda Pharmaceutical Korea’s conflict between labor and management is risi...
by Kim Yun-mi  |  2019-11-07 16:10
라인
‘One-third of heart attack survivors overlook risk of recurrence’
Amgen Korea has released findings from a survey on Korean heart attack surv...
by Lee Han-soo  |  2019-11-06 16:34
라인
AbbVie’s hepatitis C drug gets 8-week therapy regardless of cirrhosis
AbbVie said it has obtained regulatory approval for an eight-week treatment...
by Kim Yun-mi  |  2019-11-06 16:00
라인
Crystal Genomics, Daehwa win patent for patch-form arthritis drug
Crystal Genomics and Daehwa Pharmaceutical said they have registered a pate...
by Lee Han-soo  |  2019-11-06 15:57
라인
Dong-A ST's treatment of nail athlete's foot dominates local market
Dong-A ST is strengthening its position in the toenail athlete's foot t...
by Lee Han-soo  |  2019-11-06 14:09
여백
여백
여백
Back to Top